Medreich Limited — Metformin Exporter Profile
Indian Pharmaceutical Exporter · #11 for Metformin · $6.7M export value · DGFT Verified
Medreich Limited is the #11 Indian exporter of Metformin with $6.7M in export value and 133 verified shipments. Medreich Limited holds a 1.4% market share in Metformin exports across 6 countries. The company exports 42 pharmaceutical products worth $224.8M across 15 therapeutic categories.
Medreich Limited — Metformin Export Profile: Buyers & Destinations
Where Does Medreich Limited Export Metformin?
| Country | Value | Shipments | Share |
|---|---|---|---|
| JAPAN | $4.2M | 91 | 48.1% |
| UNITED KINGDOM | $3.3M | 139 | 37.8% |
| CHILE | $921.6K | 26 | 10.6% |
| AUSTRALIA | $260.3K | 9 | 3.0% |
| ECUADOR | $24.5K | 4 | 0.3% |
| HONG KONG | $10.4K | 3 | 0.1% |
| TANZANIA | $3.8K | 1 | 0.0% |
| BRAZIL | $2.0K | 5 | 0.0% |
Medreich Limited exports Metformin to 8 countries. The largest destination is JAPAN accounting for 48.1% of Medreich Limited's Metformin shipments, followed by UNITED KINGDOM (37.8%) and CHILE (10.6%). These destinations reflect Medreich Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Metformin from Medreich Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| MEDREICH PLC | UNITED KINGDOM | $2.3M | 102 |
| MEIJI SEIKA PHARMA CO.LTD | JAPAN | $1.6M | 34 |
| MEIJI SEIKA PHARMA CO., LTD. | JAPAN | $1.1M | 24 |
| MEDREICH PLC, | UNITED KINGDOM | $991.3K | 37 |
| OPKO CHILE S.A | CHILE | $494.0K | 16 |
| MEIJI SEIKA PHARMA CO LTD | JAPAN | $493.3K | 11 |
| MEIJI SEIKA PHARMA CO LIMITED | JAPAN | $450.0K | 9 |
| MEIJI SEIKA PHARMA CO. LIMITED | JAPAN | $267.3K | 6 |
| MEIJI SEIKA PHARMA CO.LTD, ODAWARA | JAPAN | $251.3K | 7 |
| OPKO CHILE SA | CHILE | $200.0K | 4 |
Medreich Limited supplies Metformin to 18 buyers globally. The largest buyer is MEDREICH PLC (UNITED KINGDOM), followed by MEIJI SEIKA PHARMA CO.LTD (JAPAN) and MEIJI SEIKA PHARMA CO., LTD. (JAPAN). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Metformin Export Value and How Much Does Medreich Limited Contribute?
India exported $266.5M worth of Metformin through 15,000 shipments from 528 suppliers to 160 countries, serving 1,475 buyers globally. Medreich Limited contributes $6.7M to this total, accounting for 1.4% of India's Metformin exports. Medreich Limited ships Metformin to 8 countries through 18 buyers.
What Is the Average Shipment Value for Medreich Limited's Metformin Exports?
Medreich Limited's average Metformin shipment value is $50.0K per consignment, based on 133 shipments totaling $6.7M. The largest destination is JAPAN (48.1% of Medreich Limited's Metformin exports).
How Does Medreich Limited Compare to Other Indian Metformin Exporters?
Medreich Limited ranks #11 among 528 Indian Metformin exporters with a 1.4% market share. The top 3 exporters are GRANULES INDIA LIMITED ($113.9M), ZENTIVA PRIVATE LIMITED ($19.4M), IPCA LABORATORIES LIMITED ($17.1M). Medreich Limited processed 133 shipments to 6 destination countries.
What Metformin Formulations Does Medreich Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| METFORMIN HYDROCHLORIDE FILM COATED TABL | $723.8K | 15 |
| (METFORMIN HYDROCHLORIDE FILM COATED TAB | $450.0K | 9 |
| METFORMIN HYDROCHLORIDE 1000MG PR TABLET | $386.4K | 10 |
| METFORMIN HCL 500MG PROLONGED RELEASE TA | $301.7K | 14 |
| METFORMIN HYDROCHLORIDE 1000MG TABLETS ( | $210.1K | 10 |
| METFORMIN HYDROCHLORIDE 500MG PROLONGED | $207.5K | 8 |
| (METFORMIN HYDROCHLORIDE FILM COATED TABLETS JP 250MG) METFORMIN HYDROCHLORIDE TABLETS JP 250MG, PACK SIZE:1045478S,QTY: | $200.0K | 4 |
| METFORMIN HYDROCHLORIDE FILM COATED TAB | $186.2K | 4 |
| METFORMIN HYDROCHLORIDE FILM COATED TABS | $136.6K | 3 |
| (METFORMIN HYDROCHLORIDE FILM COATED TABLETS JP 500MG) METFORMIN HYDROCHLORIDE TABLETS JP 500MG PO NO.MM-165 DTD 21.07.NOS | $133.5K | 3 |
Medreich Limited exports 172 distinct Metformin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is METFORMIN HYDROCHLORIDE FILM COATED TABL with 15 shipments worth $723.8K.
Regulatory Requirements: Exporting Metformin to Key Markets
What Medreich Limited must comply with to export Metformin to its top destination countries
Japan — PMDA
Approval Process
Generic Drug Application per Japan Pharmaceutical Affairs Act. Dissolution and bioequivalence studies per PMDA guidelines. Japanese data bridging often required.
Timeline: 12–24 months
GMP & Export Requirements
Japanese GMP (J-GMP); PMDA on-site inspection of Indian manufacturing facility
Foreign Manufacturer Accreditation from PMDA; Japanese MAH (Marketing Authorization Holder) partner required
Note: Japan requires Yen-denominated NHI drug price listing. Stability data under ICH Zone IVb conditions.
United Kingdom — MHRA
Approval Process
Post-Brexit UK Marketing Authorisation via national procedure. Separate from EU approval since January 2021.
Timeline: 12–15 months
GMP & Export Requirements
UK GMP compliance; MHRA inspection of manufacturing site
Manufacturer Import Authorisation (MIA) held by UK importer; Qualified Person (QP) batch release
Note: Post-Brexit: EU GMP certificates no longer automatically valid in UK. Separate MHRA recognition required.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Medreich Limited Compare to Nearest Metformin Exporters?
Exporters ranked immediately above and below #11 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 14 | AUROBINDO PHARMA LIMITED | $7.0M | 251 | 9 | $27.9K |
| 15 | HARMAN FINOCHEM LIMITED | $6.9M | 295 | 6 | $23.4K |
| 11 | MEDREICH LIMITED ★ | $6.7M | 133 | 6 | $50.0K |
| 12 | FOURRTS (INDIA) LABORATORIES PRIVATE LIMITED | $5.1M | 102 | 12 | $50.0K |
| 2 | MEDEOR LIFE CARE LLP | $3.6M | 73 | 1 | $50.0K |
Medreich Limited ranks #11 among 528 Indian Metformin exporters. Average shipment value of $50.0K compared to the market average of $504.7K. The closest competitors by value are AUROBINDO PHARMA LIMITED and HARMAN FINOCHEM LIMITED.
Which Indian Ports Ship Metformin Exports?
| Port | Shipments | % Share |
|---|---|---|
| NHAVA SHEVA SEA (INNSA1) | 2,284 | 15.2% |
| SAHAR AIR CARGO ACC (INBOM4) | 1,638 | 10.9% |
| HYDERABAD ICD (INSNF6) | 1,593 | 10.6% |
| DELHI AIR CARGO ACC (INDEL4) | 1,355 | 9.0% |
| SAHAR AIR | 1,015 | 6.8% |
| JNPT/ NHAVA SHEVA SEA | 843 | 5.6% |
| DELHI AIR | 711 | 4.7% |
| Bombay Air | 695 | 4.6% |
What Other Diabetes & Endocrine Products Does Medreich Limited Export?
Medreich Limited also exports these diabetes & endocrine products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on Medreich Limited's Metformin Exports
The current geopolitical climate presents both challenges and opportunities for Indian pharmaceutical exporters like Medreich Limited. The Israel-Iran tensions have led to disruptions in Red Sea shipping routes, resulting in increased shipping costs and extended transit times. Major shipping lines have implemented 'Emergency Risk Surcharges' ranging from $250 to $500 per TEU, directly impacting the cost structures of exporters relying on these routes. (sgeexport.com)
Conversely, the US-China trade tensions have prompted the United States to seek alternative sources for pharmaceuticals, potentially benefiting Indian exporters. However, the imposition of tariffs on pharmaceutical imports by the US poses a risk to Indian companies, as higher tariffs could render low-margin generic drugs unprofitable, leading to market exits and exacerbating drug shortages in the US. (cfo.economictimes.indiatimes.com)
The recent India-European Union Free Trade Agreement (FTA), signed in January 2026, offers a favorable development for Medreich. The FTA eliminates tariffs on Indian pharmaceutical products entering the EU, providing immediate cost relief and enhancing market access. This agreement is expected to significantly boost India's pharmaceutical exports to Europe, creating new opportunities for companies like Medreich to expand their presence in the EU market. (en.wikipedia.org)
Medreich Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. The US Food and Drug Administration (FDA), World Health Organization (WHO), and European Union Good Manufacturing Practices (EU GMP) set stringent quality requirements that companies must adhere to for market access. Recent regulatory frameworks have increased compliance costs by an average of 18.7%, leading to a 15.2% reduction in export volumes to the US in the first quarter of 2025. (transdatanexus.com)
For Medreich Limited, maintaining compliance with these evolving standards is crucial to sustaining and expanding its export markets. Investments in quality assurance, regular audits, and staying abreast of regulatory changes are essential strategies to navigate this complex landscape.
About Medreich Limited
Medreich Limited exports 42 products worth $224.8M. Beyond Metformin, top products include Amoxicillin, Potassium, Flucloxacillin, Rosuvastatin, Atorvastatin. View the complete Medreich Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Metformin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Metformin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Medreich Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 278 individual customs records matching Medreich Limited exporting Metformin, covering 172 formulations to 8 countries via 18 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 160+ countries, 1,475+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Metformin Export Data from Medreich Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Medreich Limited's Metformin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Medreich Limited
Full Company Profile →
42 products · $224.8M total trade · 15 categories
Metformin Stats
Company Overview
Top Products by Medreich Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Medreich Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Metformin. For current shipment-level data, contact TransData Nexus.